Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Alberta
Clinical trial register · Canada

Clinical Trials in Alberta, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6553 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:20 UTC
6553
Studies in scope
all four open statuses
3487
Recruiting now
open to new participants
880
Lead sponsors
across recruiting studies
Top sites
Toronto 2818 Montreal 1913 Vancouver 1187 Calgary 1068 Edmonton 1018
Narrow the registerReset
Recruitment status
Phase
Site location
Toronto2818 Montreal1913 Vancouver1187 Calgary1068 Edmonton1018 Ottawa884 London878 Hamilton811 Québec682 Halifax535 Winnipeg454 Sherbrooke264 Kingston254 Kelowna176 Brampton143 Surrey138 Victoria129 St. John's126 Barrie125 Saskatoon125 Chicoutimi100 Moncton92 Mississauga89 Greater Sudbury83 Regina82 Trois-Rivières80 Saint John75 Greenfield Park73 Oshawa73 New Westminster70 Newmarket68 North York64 Markham61 Ajax60 Windsor55 Lévis53 Kitchener49 Fredericton49 Oakville48 Waterloo47 Guelph42 Rimouski39 Burlington37 Peterborough37 Abbotsford British Columbia36 Sarnia34 Red Deer33 Scarborough Village32 Laval30 Cambridge30 Richmond Hill30 Etobicoke26 Vaughan26 Thunder Bay26 Gatineau24 Prince George22 Sault Ste. Marie21 North Vancouver20 Richmond20 Burnaby19 Sherwood Park18 Lethbridge18 Verdun18 Whitby17 Niagara Falls17 North Bay17 Sydney16 St. Catharines14 Stouffville13 Saint-Jérôme13 Saint-Charles-Borromée13 Longueuil13 Stoney Creek12 Concord11 Kentville11 Truro10 Terrebonne10 Penticton10 Courtice9 Mount Royal9 Kamloops9 Mirabel8 Victoriaville8 St. Albert7 Saint Catharines7 Winchester7 Joliette6 Brandon6 Dartmouth6 West Vancouver6 Bridgewater6 Saguenay6 Medicine Hat6 Thornhill6 Brantford5 Pointe-Claire5 Orillia5 Westmount5 Cobourg5 East York5 Nanaimo5 Ontario5 Nova Scotia4 Owen Sound4 Chilliwack4 Montral4 North YORK4 Scarborough4 Boisbriand4 Multiple Locations4 Woodbridge4 Granby4 Langley4 Sainte-Foy4 New Minas3 Canmore3 Dieppe3 Ste-Foy3 Decarie Montreal3 Many Locations3 Grande Prairie3 Winnepeg3 Chatham2 Stratford2 Belleville2 Nepean2 Saint Johns2 Saint-Georges2 Fort McMurray2 Cranbrook2 Hawkesbury2 Dundas2 Sainte-Marie2 Okanagan2 SaintJerome2 Pembroke2 Pierrefonds2 Bedford2 Alberta2 Banff2 Jonquière2 Saint-Laurent2 Edmundston2 Montréal2 Niagara2 Hanover1 Renfrew1 Drummondville1 Maria1 Miramichi1 Penetanguishene1 Norway House1 Baie-Saint-Paul1 La Malbaie1 Edmonton & Calgary1 Multiple1 North Van Couver1 Grand Prairie1 Mississagua1 Saint Isidore1 Bowmanville1 Coxheath1 Lai Chi Kok1 Sioux Lookout1 Wawa1 Piikani Nation1 Flying Dust First Nation1 Ministikwan Lake1 Onion Lake1 Waterhen Lake1 Greenville1 Fleurimont1 Saint Catherines1 Prince Albert1 Calgery1 Frederiction1 Vancouver BC1 Prince Rupert1 Sept-Îles1 Ville-Marie1 Orangeville1 Whistler1 Egypt1 Port Perry1 Newcastle1 Mira Road1 Happy Valley-Goose Bay1 Norris Point1 Woodstock1 High River1 Antigonish Nova Scotia1 Saint Jerome Quebec1 Airdrie1 Burin1 Clarenville1 Hailfax1 Alliston1 Cowansville1 Saint-Hyacinthe1 Montr Al1 Kanata1 Pickering1 Columbia1 Charlottetown1 Dalhousie1 Carbonear1 Cornwall1 Limoges1 Orléans1 Aurora1 Mission1 Dorchester1 Smiths Crossing1 Moose Jaw1 Fort Erie1 Kelowna BC1 Coburg1 Tiny1 Ganges1 Bathurst1 Bouctouche1 Campbellton1 Caraquet1 Grand Falls1 Saint-Quentin1 Pierrefonds-Roxboro1 Edmonton AB1 Montréal1 Châteauguay1 Portage la Prairie1 Denver1 Winnipeg MB1 Brockville1 Montreal, Quebec1 Weston1 Gloucester1 Emo1 Dryden1 Fort Frances1 Lakefield1 Napanee1 Hamitlon1 Laurier1 Hagersville1 Strathroy1 West Hamilton1 Don Mills1 Val-d'Or1
All 248 locations
Target enrolment
to

Trials with a site in Alberta

2 of 6553 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Not yet open
Zolbetuximab and Other Cancer Treatments in People With Advanced Gastric or GEJ Cancer in Clinical Practice (RADIANCE)
NCT07858500Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Europe Ltd.
Observational
1,000
Alberta
2027-01-31
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Alberta, Chicoutimi, Halifax, Lethbridge, London, Montreal, Québec, Scarborough
2024-07-18
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-canada/city/alberta

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,553 studies in total at the last sync on 10 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2 of those studies with a site in Alberta.

How many clinical trials are recruiting in Alberta?

1 of the 2 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:20 UTC sync. A further 1 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Alberta), 2 studies
PhaseStudiesRecruitingShare
Observational1050%
Phase 21150%

Most active sponsors

Lead sponsors with the most studies (Alberta)
Lead sponsorStudiesRecruiting
Astellas Pharma Europe Ltd.10
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.